EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MiR-449b-5p Ameliorates Hypoxia-induced Cardiomyocyte Injury through Activating PI3K/AKT Pathway by Targeting BCL2L13

Yang Jiang, Zeyan Liu, Li Ye, Jinglin Cheng, Jun Wan

Applied Biochemistry and Biotechnology · 2026

DOI: 10.1007/s12010-024-04931-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Biochemistry and Biotechnology, 2026. Verfasst von Yang Jiang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, The Second Affiliated Hospital of Anhui Medical University, No. 678 Furong Road, Jingkai District, Hefei, Anhui, 23…. Hauptthemen laut MEDLINE: MicroRNAs, Myocytes, Cardiac, Proto-Oncogene Proteins c-bcl-2, Phosphatidylinositol 3-Kinases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent reports show miR-449b-5p reduces liver and renal ischemia/reperfusion (I/R) injury, but its effects on hypoxia-induced cardiomyocyte injury in ischemic heart disease are still unknown. In this study, AC16 human cardiomyocytes underwent hypoxic conditions for durations of 24, 48, and 72 h. We observed that miR-449b-5p expression was significantly downregulated in hypoxic AC16 cardiomyocytes. Elevating the levels of miR-449b-5p in these cells resulted in enhanced cell survival, diminished release of LDH, and a reduction in cell apoptosis and oxidative stress using CCK-8, LDH assays, flow cytometry, TUNEL staining, and various commercial kits. Conversely, reducing miR-449b-5p levels resulted in the opposite effects. Through bioinformatics analysis and luciferase reporter assays, BCL2-like 13 (BCL2L13) was determined to be a direct target of miR-449b-5p. Inhibiting BCL2L13 greatly inhibited hypoxia-induced cell viability loss, LDH release, cell apoptosis, and excessive production of oxidative stress, whereas increasing BCL2L13 negated miR-449b-5p’s protective impact in hypoxic AC16 cardiomyocytes. Additionally, miR-449b-5p elevated the levels of the proteins p-PI3K, p-AKT, and Bcl-2, while decreasing Bax expression in hypoxic AC16 cardiomyocytes by targeting BCL2L13. In summary, the research indicates that the protective effects of miR-449b-5p are facilitated through the activation of the PI3K/AKT pathway, which promotes cell survival, and by targeting BCL2L13, which inhibits apoptosis, offering a potential therapeutic strategy for ischemic heart disease by mitigating hypoxia-induced cardiomyocyte injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsMyocytes, CardiacProto-Oncogene Proteins c-bcl-2Phosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSignal TransductionHumansCell HypoxiaCell LineApoptosisOxidative StressCell Survival

Stichwörter der Autor:innen

AC16 cardiomyocytesBCL2L13HypoxiaMir-449b-5pPI3K/AKT

Substanzen

MicroRNAsProto-Oncogene Proteins c-bcl-2Phosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktMIRN449 microRNA, human

Autor:innen und Institutionen

  • Department of Emergency Medicine, The Second Affiliated Hospital of Anhui Medical University, No. 678 Furong Road, Jingkai District, Hefei, Anhui, 230000, China.
  • Department of Emergency Medicine, The Second Affiliated Hospital of Anhui Medical University, No. 678 Furong Road, Jingkai District, Hefei, Anhui, 230000, China. Junwanfjzy2f@163.com.

Zitieren

APA

Jiang, Y., Liu, Z., Ye, L., Cheng, J., & Wan, J. (2026). MiR-449b-5p Ameliorates Hypoxia-induced Cardiomyocyte Injury through Activating PI3K/AKT Pathway by Targeting BCL2L13. Applied Biochemistry and Biotechnology. https://doi.org/10.1007/s12010-024-04931-5

Vancouver

Jiang Y, Liu Z, Ye L, Cheng J, Wan J. MiR-449b-5p Ameliorates Hypoxia-induced Cardiomyocyte Injury through Activating PI3K/AKT Pathway by Targeting BCL2L13. Applied Biochemistry and Biotechnology. 2026. doi:10.1007/s12010-024-04931-5

BibTeX
@article{Jiang2026,
  author = {Jiang, Yang and Liu, Zeyan and Ye, Li and Cheng, Jinglin and Wan, Jun},
  title = {MiR-449b-5p Ameliorates Hypoxia-induced Cardiomyocyte Injury through Activating PI3K/AKT Pathway by Targeting BCL2L13},
  journal = {Applied Biochemistry and Biotechnology},
  year = {2026},
  doi = {10.1007/s12010-024-04931-5}
}
Kostenlos starten →